Tiziana Life Sciences CEO Adds Company Shares-March 2024-www.financetom.com

Tiziana Life Sciences CEO Adds Company Shares

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Tiziana Life Sciences CEO Adds Company Shares

Sep 9, 2025 7:47 AM

10:43 AM EDT, 09/09/2025 (MT Newswires) -- Tiziana Life Sciences ( TLSA ) said Tuesday that Chief Executive Officer Ivor Elrifi has bought has purchased 14,848 shares of the company at $1.65 per share.

The purchase raised his holding to 193,848 shares, the firm said.

Shares were up over 11% in recent trading.

Price: 1.81, Change: +0.19, Percent Change: +11.42

Previous page： Google invests in Intersect Power in over $800 mln funding round amid AI race Next page： SiriusXM Updates Strategic Plan, Provides 2025 Revenue Outlook

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Google invests in Intersect Power in over $800 mln funding round amid AI race

Dec 10, 2024

Dec 10 (Reuters) - Alphabet's Google, along with TPG Rise Climate and other investors, is backing clean energy developer Intersect Power as part more than $800 million funding round, the company said on Tuesday. Google's capital investment in Intersect Power comes as the tech giant, like other hyperscalers including Microsoft ( MSFT ) and Meta, races to bolster its domestic...

SiriusXM Updates Strategic Plan, Provides 2025 Revenue Outlook

Dec 10, 2024

09:10 AM EST, 12/10/2024 (MT Newswires) -- SiriusXM Holdings (SIRI) unveiled Tuesday an updated strategic plan that sharpens its focus on its core subscription business and issued 2025 revenue guidance below analysts' expectations. The company expects full-year 2025 revenue of $8.5 billion. Analysts polled by FactSet are forecasting $8.74 billion. SiriusXM also said that an authorized $1.17 billion stock repurchase...

Akoya Biosciences Secures Exclusive License for NeraCare's Immunoprint Test

Dec 10, 2024

09:03 AM EST, 12/10/2024 (MT Newswires) -- Akoya Biosciences ( AKYA ) said Tuesday that it has signed an exclusive global license agreement with NeraCare to develop and commercialize the Immunoprint test on Akoya's multiplexed immunofluorescent platform. The agreement grants Akoya rights to develop and market the test for clinical research, diagnostic development, or patient testing following regulatory approval, Akoya...

Google invests in Intersect Power in over $800 million funding round amid AI race

Dec 10, 2024

(Reuters) - Alphabet's Google, along with TPG Rise Climate and other investors, is backing clean energy developer Intersect Power as part more than $800 million funding round, the company said on Tuesday. Google's capital investment in Intersect Power comes as the tech giant, like other hyperscalers including Microsoft and Meta, races to bolster its domestic data center capacity to meet...